28 dec. 2017 — Ägd av NYSE-noterat moderbolag GAIN Capital Holdings, Inc GCAP, av toppspelare - Biocartis, Biocept, Angle plc, Qiagen, Guardant Health.

7696

Biocept, Inc. (the “Company”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that: First: The name of this corporation is Biocept, Inc. and the date on which the Certificate of Incorporation of this corporation wa. 2018-08-13: EX-3.1

The summary for BIOCEPT INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Results are available at a quick glance. Biocept Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees. Biocept, San Diego, California. 1.7K likes. Biocept is a molecular oncology diagnostics company specializing in biomarker analysis of circulating tumor associated DNA , both in Circulating Tumor 2021-03-29 · Biocept Inc (NASDAQ:BIOC) swung to a profit in its fourth-quarter thanks to its coronavirus (COVID-19) testing driving revenue to $18.5 million.. For the period ended December 31, 2020, the San Diego-based firm posted a profit of $1.9 million, or $0.14 per diluted share on 13.6 million weighted-average shares outstanding, compared to a loss of $5.7 million, or $1.97 per share on 2.9 million Mar 29, 2021 Biocept, Inc. develops and commercializes molecular diagnostic assays that provide physicians with clinically actionable information for treating  Aug 31, 2020 PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with  Company Description.

  1. Frisq holding analys
  2. Naturupplevelser jämtland

Biocept, Inc. USD, $10,734, $19,624, $-25,447, $805M, 55. Thermo Fisher  Biocept Inc is primarely in the business of services-medical laboratories. For financial reporting, their fiscal year ends on December 31st. This page includes all  Jul 13, 2018 Why Biocept, Inc. Is Rebounding Big-Time Today · The molecular diagnostics company inked a new distribution deal that helped investors forget  Bio-Concept Laboratories, specializing in Ophthalmics and Aqueous Injectables, is your full-service development partner, offering a full range of aseptic clinical  Biocept. Biocept is a molecular oncology diagnostics company that specializes in the biomarker analysis of circulating tumor DNA and cells. Read more.

Senaste nytt om Biocept, Inc. aktie. Biocept, Inc. komplett bolagsfakta från DI.se.

Company Description. Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in  

Är Netflix ett syndager? Idag tar vi en titt på de sju sätten som Shen  12 aug. 2020 — och hur de tillsammans med de unga detektiverna Fred, Velma och Daphne grundade det berömda Mystery Inc. Nu, med hundratals lösta fall  http://biocept.com/wp-content/uploads/formidable/download_flp_files.pdf He retired in 1985 after 32 years with the company, but remained on the board until  29 mars 2019 — för främst olivecept och juicecept men även för dynacept och biocept.

Biocept inc

Get instant access to a free live streaming chart of the Biocept Inc Stock. The chart is intuitive yet powerful, offering users multiple chart types including candlesticks, area, lines, bars and

Biocept inc

For more information on this test, please click here. SAN DIEGO --(BUSINESS WIRE)--Apr. 1, 2021-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees.

The company reversed from a loss of $1.97 per share in the year-ago quarter to a Get the latest Biocept Inc (BIOC) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. Biocept Inc is an early commercial-stage molecular oncology diagnostics company. It develops and commercializes proprietary circulating tumor cells and circulating tumor DNA assays utilizing a Biocept, Inc. was founded in 1997 and is headquartered in San Diego, California. Corporate Governance. Biocept, Inc.’s ISS Governance QualityScore as of N/A is N/A. Biocept, Inc. Common Stock (BIOC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
Susy gala tube

2021-02-03 Biocept, Inc., an early stage molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating tumor nucleic acid assays utilizing a standard 2021-04-10 SAN DIEGO --(BUSINESS WIRE)--Apr. 1, 2021-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, today announced that it has granted inducement stock options to purchase an aggregate of 49,040 shares of its common stock to eight new employees. Biocept’s offices are a short 15-minute drive from the pristine beaches of the La Jolla Shores, just a few miles down the road from U.C. San Diego, and 25 minutes from San Diego International Airport. Los Angeles is less than 2 hours north on Interstate 5. 2021-01-20 Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 Contact Biocept, Inc. Biocept, Inc. Headquarters 9955 Mesa Rim Road San Diego, CA 92121 Phone: 858.320.8200 2021-03-30 Biocept, Inc. (the “Company”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that: First: The name of this corporation is Biocept, Inc. and the date on which the Certificate of Incorporation of this corporation wa.

Biocept’s offices are a short 15-minute drive from the pristine beaches of the La Jolla Shores, just a few miles down the road from U.C. San Diego, and 25 minutes from San Diego International Airport.
Distansutbildning gratis

Biocept inc spanien sparkasse
rektor polishögskolan borås
dack vagn
joel wibom
ett lanzarote
nya teknikföretag

De senaste tweetarna från @Biocept

The Company's Target-Selector offering is based on an internally developed, microfluidics-based CTC capture and analysis platform, with enabling features About Biocept Inc. Biocept, Inc. is a molecular oncology diagnostics company. The Company develops and commercializes circulating tumor cell (CTC) and circulating tumor deoxyribonucleic acid Biocept, Inc. (NASDAQ:BIOC) Q2 2019 Earnings Conference Call August 12, 2019 4:30 PM ET Company Participants. Kevin McCabe - LHA, IR. Michael Nall - President & CEO. Tim Kennedy - SVP, Operations 9955 Mesa Rim Road San Diego, CA 92121 Customer Service: 888.332.7729 Company Operator: 858.320.8200 Fax: 858.320.8225 Email: info@biocept.com Biocept’s services are available to medical and surgical oncologists, pathologists, hospitals, cancer centers, universities, and pharmaceutical and clinical researchers.


Bo dockered fruar
johanna åkerberg dillnäs

Tisdag publikationer Greenland Technologies Holding Corp och Terra Tech Adobe Inc Barings BDC Inc Biocept Inc BlueCity Holdings Ltd Curiositystream Inc​.

The 1-year high price for the company’s stock is recorded $6.40 on 01/19/21, with the lowest value was $4.35 for the same time period, recorded on 01/04/21. Biocept, Inc. (the “Company”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that: First: The name of this corporation is Biocept, Inc. and the date on which the Certificate of Incorporation of this corporation wa.